SEC Files Settled Action Charging Ex-Biopharmaceutical Company Employee & Due Diligence Team Member for Insider Trading
July 10, 2026
July 10, 2026
WASHINGTON, July 10 -- The Securities and Exchange Commission issued the following litigation release (No. 8:26-cv-02694; D. Md. filed July 8, 2026) involving an ex-biopharmaceutical company employee and due diligence team member for insider trading:
* * *
On July 8, 2026, the Securities and Exchange Commission filed settled insider trading charges against Maryland resident Weiguo Zhai, for illegally trading securities before the December 12, 2023 public announcement of . . .
* * *
On July 8, 2026, the Securities and Exchange Commission filed settled insider trading charges against Maryland resident Weiguo Zhai, for illegally trading securities before the December 12, 2023 public announcement of . . .